The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model Tamar TadmorYu ZhangJoseph D. Rosenblatt Original Article 21 January 2011 Pages: 609 - 619
Impact of minimal tumor burden on antibody response to vaccination Soo-Kie KimXiaohong WuPhilip O. Livingston Original article 26 January 2011 Pages: 621 - 627
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine Elizabeth A. VasievichWeihsu ChenLeaf Huang Original Article 26 January 2011 Pages: 629 - 638
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC Christina BattkeRomana RuissReinhard Zeidler Original article 04 February 2011 Pages: 639 - 648
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII Christina BattkeElisabeth KremmerReinhard Zeidler Original article 05 February 2011 Pages: 649 - 658
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity Hidekazu ShirotaDennis M. Klinman Original Article 04 February 2011 Pages: 659 - 669
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice Sally M. AmosHollie J. PegramMichael H. Kershaw Original article 16 February 2011 Pages: 671 - 683
Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction Jonathan H. LeeYun ChenJames S. Goydos Original article 16 February 2011 Pages: 685 - 692
TH1 predominance is associated with improved survival in pediatric medulloblastoma patients Verena WiegeringMatthias EyrichBeate Winkler Original article 16 February 2011 Pages: 693 - 703
An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity Mingkai XuXiaogang WangChenggang Zhang Original article 18 February 2011 Pages: 705 - 713
Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer Qiushan HeJinlong LiJimin Gao Original article 18 February 2011 Pages: 715 - 730
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model Brenda L. SotoJacquelyn A. HankPaul M. Sondel Original Article 22 February 2011 Pages: 731 - 738
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells Shicheng YangGattinoni LucaRichard A. Morgan Original article 09 February 2011 Pages: 739 - 749
Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells Shicheng YangLuca GattinoniRichard A. Morgan Erratum 02 March 2011 Pages: 751 - 751
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010 Maria C. OchoaSandra Hervas-StubbsIgnacio Melero Meeting Report 05 March 2011 Pages: 753 - 756
